[Isl] Fwd: Deadline Reminder: Harrington Discovery Institute Funding Opportunities

Fri May 31 18:40:05 EDT 2024

Dear colleagues,

Forwarding upcoming grant opportunities. Please see below. Let me know how I can help!

Best
Zhe
—
Zhe He, PhD, FAMIA
Interim Director, Institute for Successful Longevity https://isl.fsu.edu/<https://nam04.safelinks.protection.outlook.com/?url=https%3A%2F%2Fisl.fsu.edu%2F&data=05%7C02%7Cisl%40lists.fsu.edu%7C870e82f9339e4e97207708dc81c29e33%7Ca36450ebdb0642a78d1b026719f701e3%7C0%7C0%7C638527920079984122%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&sdata=WMXjq4pWB8MRqiXSfcndh152TEIAXiCHNio7hs4TWqc%3D&reserved=0>
Associate Professor, School of Information, College of Communication and Information

Begin forwarded message:

From: Rachel Goff-Albritton <r.goffalbritton at fsu.edu>
Date: May 30, 2024 at 9:48:37 AM EDT
To: Zhe He <Zhe.He at cci.fsu.edu>
Subject: Fwd: Deadline Reminder: Harrington Discovery Institute Funding Opportunities

Upcoming LOI deadline June 3 for work in Alzheimer's disease and related dementias- wanted to share!

Rachel Goff-Albritton, Ph.D., CCC-SLP
Assistant Director, Research Development and Mentoring
Research Development, Office of Research

Florida State University, Office of the Vice President for Research
2021 Westcott North Annex Tallahassee, FL. 32306-1330
850-644-3044 / r.goffalbritton at fsu.edu
https://www.research.fsu.edu/research-offices/opd/

From: Koopman, Rebecca M <Rebecca.Koopman at HarringtonDiscovery.org>
Sent: Thursday, May 30, 2024 7:53 AM
To: Koopman, Rebecca M <Rebecca.Koopman at HarringtonDiscovery.org>
Subject: Deadline Reminder: Harrington Discovery Institute Funding Opportunities
Importance: High

Hello –

This is a gentle reminder about three Harrington Discovery Institute grant funding opportunities that are now open and calling for submissions. We are hoping to enlist your help in spreading the word.

Since our institute’s founding in 2012, we have funded 188 scholars from 66 universities in the US, UK and Canada; supported the launch of 39 companies; and have helped advance 21 medicines into the clinic.

We would appreciate if you could kindly share the following information with your network to make your Investigators aware. Want to receive future funding opportunities? Please join our email list here<https://nam04.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.harringtondiscovery.org%2Fcontact&data=05%7C02%7Cisl%40lists.fsu.edu%7C870e82f9339e4e97207708dc81c29e33%7Ca36450ebdb0642a78d1b026719f701e3%7C0%7C0%7C638527920083109336%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&sdata=0diDHiK1fybrnvqaHNoi7cyDfpzFCs%2BOGjrfgpzYamI%3D&reserved=0>.

HARRINGTON SCHOLAR-INNOVATOR AWARD
M.D. required for eligibility. Open to physician-scientists in the US and Canada.
Letters of Intent (LOI) Due: June 5, 2024

Harrington Discovery Institute invites you to submit a brief letter of intent (LOI) for the 2025 Harrington Scholar-Innovator Award. This grant supports all disease areas and is designed to advance promising drug discovery research towards the clinic. Up to 10 Scholar-Innovators will be selected to receive:

  *   $100,000 guaranteed grant award;
  *   Drug and business development support from Harrington’s Therapeutics Development Center<https://nam04.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.harringtondiscovery.org%2Fabout%2Ftherapeutics-development-center&data=05%7C02%7Cisl%40lists.fsu.edu%7C870e82f9339e4e97207708dc81c29e33%7Ca36450ebdb0642a78d1b026719f701e3%7C0%7C0%7C638527920083109336%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&sdata=T396kUNK6Rku9oL881A03Y3l7PlSzxK9V3IcdjfjY5s%3D&reserved=0> advisors;
  *   Opportunity to compete for acceleration funds up to $300,000;
  *   Opportunity to quality for investment funds typically up to $2MM.

Pending how far an applicant makes it in the review process, Harrington Discovery Institute may be able to provide reviewers’ comments and feedback to help the applicant strengthen the proposal for future submission.

Visit our website to learn more<https://nam04.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.harringtondiscovery.org%2Ffunding%2Fharrington-scholar-innovator&data=05%7C02%7Cisl%40lists.fsu.edu%7C870e82f9339e4e97207708dc81c29e33%7Ca36450ebdb0642a78d1b026719f701e3%7C0%7C0%7C638527920083109336%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&sdata=nXzptujK9kHG1RPIkG%2BCmV5WjN5LzRNAYJvTGpGOd8A%3D&reserved=0> about the Harrington Scholar-Innovator program.
To submit an LOI online, go to our grant system<https://nam04.safelinks.protection.outlook.com/?url=https%3A%2F%2Fharringtondiscovery.smartsimple.com%2Fs_Login.jsp%3Flang%3D1%26prole%3D0&data=05%7C02%7Cisl%40lists.fsu.edu%7C870e82f9339e4e97207708dc81c29e33%7Ca36450ebdb0642a78d1b026719f701e3%7C0%7C0%7C638527920083109336%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&sdata=74JYE0qsuNEC1L5k9oCcihE2YJ%2Fx3TdLfRs7swkkYiA%3D&reserved=0> and create an account.
Questions? Email Questions at HarringtonDiscovery.org<mailto:Questions at HarringtonDiscovery.org>.

ADDF-HARRINGTON SCHOLAR AWARD
Ph.D. or M.D. or equivalent required for eligibility. Open to researchers in the US, UK and Canada.
Letters of Intent (LOI) Due: June 3, 2024

Harrington Discovery Institute and the Alzheimer’s Drug Discovery Foundation (ADDF) invite you to submit a letter of intent (LOI) for the 2024 ADDF-Harrington Scholar Award. This grant is designed to accelerate the translation of academic discoveries into medicines for treating, preventing, or curing patients with Alzheimer’s disease and related dementias. Of particular interest are targets related to proteostasis and senescence. Researchers working on drug development programs that are relevant to, but not presently focused on, the Alzheimer’s field are strongly encouraged to apply. In addition to grant funding, Harrington Discovery Institute provides guidance and oversight in all aspects of drug development, while taking no rights to intellectual property, which is retained by you/your institution.

Pending how far an applicant makes it in the review process, Harrington Discovery Institute may be able to provide reviewers’ comments and feedback to help the applicant strengthen the proposal for future submission.

Visit our website to learn more<https://nam04.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.harringtondiscovery.org%2Ffunding%2Faddf-harrington&data=05%7C02%7Cisl%40lists.fsu.edu%7C870e82f9339e4e97207708dc81c29e33%7Ca36450ebdb0642a78d1b026719f701e3%7C0%7C0%7C638527920083109336%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&sdata=kuTKktQKny0%2BJK%2BWzcp1kPxYuz3VZa5yN0XdpgyME8A%3D&reserved=0> about the ADDF-Harrington Scholar program.
To submit your LOI online, go to ADDF’s grant system<https://nam04.safelinks.protection.outlook.com/?url=https%3A%2F%2Faddf.fluxx.io%2Fuser_sessions%2Fnew&data=05%7C02%7Cisl%40lists.fsu.edu%7C870e82f9339e4e97207708dc81c29e33%7Ca36450ebdb0642a78d1b026719f701e3%7C0%7C0%7C638527920083109336%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&sdata=E0GiONX2k2JkcyXitYwQ7%2BPIao3fIMNECqeGBfXM%2BZA%3D&reserved=0> and create an account.
Questions? Email grants at alzdiscovery.org<mailto:grants at alzdiscovery.org> or Questions at HarringtonDiscovery.org<mailto:Questions at HarringtonDiscovery.org>.
Scientific inquiries? Email Meriel Owen, PhD, ADDF at mowen at alzdiscovery.org<mailto:mowen at alzdiscovery.org>.

BRAIN HEALTH MEDICINES SCHOLAR AWARD
Ph.D. or M.D. or equivalent required for eligibility. Open to researchers in the US, UK and Canada.
Submission Deadlines: March 31, June 30, September 30 and December 31 annually
Applications can be submitted at any time and will be reviewed on a quarterly basis.

Harrington Discovery Institute invites you to submit an application for the 2024 Brain Health Medicines Scholar Award. This grant is designed to accelerate the translation of academic discoveries into medicines for treating, preventing, or curing patients with Alzheimer’s disease and related dementias. In addition to grant funding, Harrington Discovery Institute provides guidance and oversight in all aspects of drug development, while taking no rights to intellectual property, which is retained by you/your institution.

Pending how far an applicant makes it in the review process, Harrington Discovery Institute may be able to provide reviewers’ comments and feedback to help the applicant strengthen the proposal for future submission.

Visit our website to learn more<https://nam04.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.harringtondiscovery.org%2Ffunding%2Fbrain-health-medicines&data=05%7C02%7Cisl%40lists.fsu.edu%7C870e82f9339e4e97207708dc81c29e33%7Ca36450ebdb0642a78d1b026719f701e3%7C0%7C0%7C638527920083265542%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&sdata=P97bRMOUy8TcXW7oxmi87a2ZUUri5cwj3pM0PJl0ZqE%3D&reserved=0> about the ADDF-Harrington Scholar program.
To submit an application online, go to our grant system<https://nam04.safelinks.protection.outlook.com/?url=https%3A%2F%2Fharringtondiscovery.smartsimple.com%2Fs_Login.jsp%3Flang%3D1%26prole%3D0&data=05%7C02%7Cisl%40lists.fsu.edu%7C870e82f9339e4e97207708dc81c29e33%7Ca36450ebdb0642a78d1b026719f701e3%7C0%7C0%7C638527920083265542%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&sdata=uu2qKoBw52wBMum2JiZTbm5bY5ye7Mr3BwoFWcPpcts%3D&reserved=0> and create an account.
Questions? Email Questions at HarringtonDiscovery.org<mailto:Questions at HarringtonDiscovery.org>.

Please feel free to reach out with any questions or concerns.

Becca Koopman
Project Manager Associate, Programs
Harrington Discovery Institute

HarringtonDiscovery.org<https://nam04.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.harringtondiscovery.org%2F&data=05%7C02%7Cisl%40lists.fsu.edu%7C870e82f9339e4e97207708dc81c29e33%7Ca36450ebdb0642a78d1b026719f701e3%7C0%7C0%7C638527920083265542%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&sdata=itvdR0w5V7xWykPSYfvbBhny%2BHueddFlNWDk%2B0sQhOU%3D&reserved=0>

Download our latest Annual Publication First Ten Years: Accelerating Discoveries into Medicines<https://nam04.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.harringtondiscovery.org%2F2021-2022-Publication&data=05%7C02%7Cisl%40lists.fsu.edu%7C870e82f9339e4e97207708dc81c29e33%7Ca36450ebdb0642a78d1b026719f701e3%7C0%7C0%7C638527920083265542%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&sdata=OwGiSo32lR7bdoZgttARQhgVuBGlOnry137Q%2BuyEbhQ%3D&reserved=0>

________________________________
Visit us at www.UHhospitals.org<https://nam04.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.uhhospitals.org%2F&data=05%7C02%7Cisl%40lists.fsu.edu%7C870e82f9339e4e97207708dc81c29e33%7Ca36450ebdb0642a78d1b026719f701e3%7C0%7C0%7C638527920083265542%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&sdata=k1AFN7LDC1cKcCylvDR3M2gCwt6F0xzptZM2fT2M0Sw%3D&reserved=0>.

The enclosed information is STRICTLY CONFIDENTIAL and is intended for the
use of the addressee only. University Hospitals and its affiliates disclaim
any responsibility for unauthorized disclosure of this information to anyone
other than the addressee.

Federal and Ohio law protect patient medical information, including
psychiatric_disorders, (H.I.V) test results, A.I.Ds-related conditions,
alcohol, and/or drug_dependence or abuse disclosed in this email. Federal
regulation (42 CFR Part 2) and Ohio Revised Code section 5122.31 and
3701.243 prohibit disclosure of this information without the specific
written consent of the person to whom it pertains, or as otherwise permitted
by law.
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.fsu.edu/pipermail/isl/attachments/20240531/f0503a23/attachment-0001.html>